STOCK TITAN

Director Brown converts RSUs at 908 Devices (MASS) into shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

908 Devices Inc. director Christopher D. Brown reported the settlement of three batches of restricted stock units (RSUs) into Common Stock on February 1, 2026. RSUs covering 5,027, 7,418, and 10,992 shares converted into the same number of Common shares at an exercise price of $0 per share.

Following these vesting events, Brown directly beneficially owns 985,559 shares of Common Stock and 21,982 RSUs. The RSU awards vest in four substantially equal annual installments on anniversary dates following February 1, 2022, February 1, 2023, and February 1, 2024, subject to his continued service.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Brown Christopher D.

(Last) (First) (Middle)
C/O 908 DEVICES INC.
44 3RD AVENUE

(Street)
BURLINGTON MA 01803

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
908 Devices Inc. [ MASS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
02/01/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/01/2026 M 5,027 A (1) 967,149 D
Common Stock 02/01/2026 M 7,418 A (1) 974,567 D
Common Stock 02/01/2026 M 10,992 A (1) 985,559 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (1) 02/01/2026 M 5,027 (2) (2) Common Stock 5,027 $0 0 D
Restricted Stock Units (1) 02/01/2026 M 7,418 (3) (3) Common Stock 7,418 $0 7,418 D
Restricted Stock Units (1) 02/01/2026 M 10,992 (4) (4) Common Stock 10,992 $0 21,982 D
Explanation of Responses:
1. Each Restricted Stock Unit ("RSU") represents a contingent right to receive, at settlement, one share of Common Stock. This transaction represents the settlement of RSUs in shares of Common Stock on their scheduled vesting date.
2. These RSUs vest in four substantially equal annual installments at the four anniversary dates following February 1, 2022, subject to the reporting person's continued service through the applicable vesting date. The RSUs have no expiration date.
3. These RSUs vest in four substantially equal annual installments at the four anniversary dates following February 1, 2023, subject to the reporting person's continued service through the applicable vesting date. The RSUs have no expiration date.
4. These RSUs vest in four substantially equal annual installments at the four anniversary dates following February 1, 2024, subject to the reporting person's continued service through the applicable vesting date. The RSUs have no expiration date.
/s/ Mark S. Levine, Attorney-in-Fact 02/03/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
908 Devices Inc.

NASDAQ:MASS

MASS Rankings

MASS Latest News

MASS Latest SEC Filings

MASS Stock Data

224.40M
33.18M
8.37%
83.39%
5.43%
Medical Devices
Measuring & Controlling Devices, Nec
Link
United States
BURLINGTON